Gastrointestinal stromal tumor (GIST), a type of tumor usually found in the stomach or small intestine,. It is unique because it responds to newer biologicals, such as GLeevec or Tasigna. Although there are those who recommend routine surveillance for this difficult to follow cancer(Choi et al), unfortuntely, prospective data and a consensus for guidelines concerning the screening of asymptomatic high risk patients and surveillance following multidisciplinary treatment do not exist for GIST. NCCN does not recommend routine surveillance after treatment of GIST.
Read the Professional version here.